Stay updated on Adjuvant Pembrolizumab in N2+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Adjuvant Pembrolizumab in N2+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adjuvant Pembrolizumab in N2+ NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the older funding-status notice (v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T04:55:27.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Added a site-wide notice about funding status and operations and updated the page version from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T04:36:15.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated footer notes to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while removing the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T02:58:27.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A reference to the 1994 NEJM randomized trial on preoperative chemotherapy plus surgery versus surgery alone in NSCLC was added to the page.
    Difference
    0.1%
    Check dated 2026-01-21T03:22:13.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision tag updated to v3.3.4, replacing the previous v3.3.3; this is an internal versioning update with no effect on study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:43:35.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Footer updated to show Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T13:27:36.000Z thumbnail image

Stay in the know with updates to Adjuvant Pembrolizumab in N2+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adjuvant Pembrolizumab in N2+ NSCLC Clinical Trial page.